Riyadh Hosts 3rd Global Medical Biotechnology Summit to Propel Saudi Vision 2030

November 15, 2024 02:42 AM NZDT | By EIN Presswire
 Riyadh Hosts 3rd Global Medical Biotechnology Summit to Propel Saudi Vision 2030
Image source: EIN Presswire

Under HRH Prince Mohammed bin Salman’s patronage, Riyadh hosts the 3rd Global Medical Biotechnology Summit (RGMBS-2024) to advance Saudi Vision 2030, Nov 10-12. RIYADH, RIYADH, SAUDI ARABIA, November 14, 2024 /EINPresswire.com/ -- Under the Patronage of HRH Prince Mohammed bin Salman, Riyadh Hosts 3rd Global Medical Biotechnology Summit to Propel Saudi Vision 2030

Under the patronage of His Royal Highness Prince Mohammed bin Salman bin Abdulaziz Al Saud, Crown Prince and Prime Minister – may God protect him – the Ministry of National Guard, through its Health Affairs division, is organizing the 3rd edition of the Riyadh Global Medical Biotechnology Summit (RGMBS-2024) in collaboration with the Ministry of Investment, the summit's strategic partner. The event is scheduled to take place from the 8th to the 10th of Jumada I, 1446 AH, corresponding to November 10th to 12th, 2024, in Riyadh.

In line with Saudi Vision, the RGMBS aims to enhance sustainable development and bolster the national economy within this vital sector. The summit supports the goals of the National Biotechnology Strategy, launched by His Royal Highness the Crown Prince – may God protect him – at the beginning of 2024. This strategy outlines the Kingdom's vision for advancing biotechnology across key sectors, including medicine, agriculture, environment, and industry, with aspirations to establish the Kingdom as a regional leader in biotechnology in the Middle East and North Africa by 2030 and a global hub by 2040.

The biotechnology is one of the centerstones for the Kingdom's Vision 2030, which seeks to foster a vibrant and productive society and a sustainable economy by emphasizing research and technological development, and promoting the values of knowledge, innovation, and science.

The summit will feature global leaders and experts in medical biotechnology, alongside representatives from prominent companies from the United States, the United Kingdom, China, Korea, Japan, and other pioneers in biotechnology, pharmaceuticals, and medical technology. Esteemed academic organizations and institutions with significant contributions to the biotechnology sector will also participate, solidifying the summit's status as a premier event in the regional and global health landscape.

The previous edition of the summit resulted in the signing of 11 cooperation agreements with global entities in medical technology research, vaccine production, and knowledge localization. It also hosted 68 local and international speakers and attracted over 14,300 participants from 128 countries worldwide. For more information, please visit the summit's official website: rgmbs.org.

Mohamed Saleh
Mohamed Saleh
email us here

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.


Disclaimer

The content on this website, including, but not limited to, any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations, and video (“Content”) is a service provided by Kalkine Media New Zealand Limited, Company Number 8107196 and NZBN 9429018590709 (“Kalkine Media, we or us”) and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide financial advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests users seek financial advice from a financial advice provider, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all liability to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without any express or implied warranties of any kind. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content. Some of the images/music that may be used on this website are copyrighted to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit a source wherever it is indicated or is found to be necessary or desirable.
This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.


Sponsored Articles


We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.